{"log_id": 3694409815707547292, "direction": 0, "words_result_num": 22, "words_result": [{"probability": {"variance": 1.8e-05, "average": 0.998426, "min": 0.97505}, "location": {"width": 781, "top": 216, "height": 27, "left": 255}, "words": "有心脏疾病(冠心病、病窦综合征、低血压、变异型心绞痛、心衰)的患者,使用噻吗"}, {"probability": {"variance": 3e-06, "average": 0.999147, "min": 0.992551}, "location": {"width": 824, "top": 263, "height": 28, "left": 212}, "words": "洛尔治疗时应进行严格的评估,应该考虑使用其他活性成分治疗。有心脏病史的患者治疗中"}, {"probability": {"variance": 4e-06, "average": 0.998917, "min": 0.990981}, "location": {"width": 417, "top": 311, "height": 27, "left": 213}, "words": "应监察此类心脏疾病恶化以及不良反应的体征"}, {"probability": {"variance": 0.009123, "average": 0.973749, "min": 0.533751}, "location": {"width": 737, "top": 405, "height": 29, "left": 254}, "words": "由于其对传导时间有负面影响,一度心脏传导阻滞的患者应该慎用β-受体阻滞剂"}, {"probability": {"variance": 0.002223, "average": 0.991042, "min": 0.708387}, "location": {"width": 756, "top": 498, "height": 28, "left": 252}, "words": "严重周围循环障碍/疾病患者(即雷诺氏病的严重形式或雷诺氏综合症)应谨慎使用"}, {"probability": {"variance": 0.003673, "average": 0.988757, "min": 0.620448}, "location": {"width": 783, "top": 591, "height": 28, "left": 254}, "words": "已有报道,使用马来酸噻吗洛尔会发生呼吸系统反应和心脏反应,包括哮喘病人因支气"}, {"probability": {"variance": 1.6e-05, "average": 0.998347, "min": 0.984408}, "location": {"width": 293, "top": 638, "height": 27, "left": 213}, "words": "管痉挛致死以及罕见的心衰死亡"}, {"probability": {"variance": 0.005792, "average": 0.976674, "min": 0.533489}, "location": {"width": 784, "top": 731, "height": 28, "left": 251}, "words": "轻度/中度慢性阻塞性肺疾病(COPD)患者应仅在潜在获益犬于潜在风险时,慎用马来"}, {"probability": {"variance": 6.3e-05, "average": 0.995573, "min": 0.979803}, "location": {"width": 108, "top": 780, "height": 25, "left": 211}, "words": "酸噻吗洛尔"}, {"probability": {"variance": 0.000374, "average": 0.99433, "min": 0.906654}, "location": {"width": 765, "top": 868, "height": 31, "left": 252}, "words": "自发性低血糖和不稳定性胰岛素依赖型糖尿病的病人应慎用B受体阻滞剂,因为β"}, {"probability": {"variance": 0.000595, "average": 0.993681, "min": 0.844253}, "location": {"width": 821, "top": 918, "height": 28, "left": 212}, "words": "受体阻滞剂可能掩盖急性低血糖的症状和体征。β一受体阻滞剂还可能掩盖甲状腺机能亢进"}, {"probability": {"variance": 1e-06, "average": 0.998418, "min": 0.997141}, "location": {"width": 64, "top": 968, "height": 23, "left": 212}, "words": "的体征"}, {"probability": {"variance": 0.000632, "average": 0.987324, "min": 0.937031}, "location": {"width": 91, "top": 1060, "height": 26, "left": 211}, "words": "过敏反应:"}, {"probability": {"variance": 0.005281, "average": 0.981454, "min": 0.66012}, "location": {"width": 760, "top": 1104, "height": 27, "left": 253}, "words": "当有遗传性过敏症史或对多种过敏原有严重过敏反应史的病人使用B一受体阻滞剂时"}, {"probability": {"variance": 8e-06, "average": 0.998722, "min": 0.986446}, "location": {"width": 506, "top": 1150, "height": 29, "left": 208}, "words": "对用于治疗过敏反应的常规剂量的肾上腺素可能无反应"}, {"probability": {"variance": 0, "average": 0.999928, "min": 0.999843}, "location": {"width": 104, "top": 1249, "height": 25, "left": 209}, "words": "伴随治疗:"}, {"probability": {"variance": 1.6e-05, "average": 0.998179, "min": 0.978511}, "location": {"width": 644, "top": 1291, "height": 28, "left": 251}, "words": "噻吗洛尔与其它药物间可能存在药物相互作用,参见【药物相互作用】"}, {"probability": {"variance": 0.001341, "average": 0.987285, "min": 0.818698}, "location": {"width": 784, "top": 1385, "height": 28, "left": 250}, "words": "接受口服β一受体阻滞剂治疗的病人使用本品,对眼压的作用或已知的全身β一受体阻"}, {"probability": {"variance": 9.8e-05, "average": 0.996174, "min": 0.95645}, "location": {"width": 783, "top": 1430, "height": 30, "left": 210}, "words": "滞作用可能增强。不推荐同时使用两种局部β一受体阻滞剂或两种局部前列腺素类药物"}, {"probability": {"variance": 5e-06, "average": 0.998188, "min": 0.993762}, "location": {"width": 103, "top": 1530, "height": 27, "left": 209}, "words": "眼部作用:"}, {"probability": {"variance": 8.7e-05, "average": 0.994, "min": 0.976684}, "location": {"width": 138, "top": 1581, "height": 25, "left": 557}, "words": "第6页,共14页"}, {"probability": {"variance": 5.1e-05, "average": 0.994447, "min": 0.97612}, "location": {"width": 73, "top": 1609, "height": 18, "left": 301}, "words": "20130506"}], "language": 3}